Vitamin Shoppe Inc. (NYSE:VSI) has earned a consensus rating of “Hold” from the twelve research firms that are presently covering the stock. One investment analyst has rated the stock with a sell rating, ten have assigned a hold rating and one has assigned a buy rating to the company. The average 1-year target price among analysts that have covered the stock in the last year is $33.00.

VSI has been the topic of several research analyst reports. Zacks Investment Research downgraded Vitamin Shoppe from a “buy” rating to a “hold” rating in a research note on Wednesday, August 3rd. Wedbush reiterated an “outperform” rating and issued a $39.00 price objective on shares of Vitamin Shoppe in a research note on Wednesday, August 3rd. Finally, Jefferies Group reiterated a “hold” rating on shares of Vitamin Shoppe in a research note on Thursday, August 4th.

Several large investors have recently modified their holdings of the company. Carlson Capital L P increased its stake in shares of Vitamin Shoppe by 0.5% in the second quarter. Carlson Capital L P now owns 2,308,983 shares of the company’s stock worth $70,586,000 after buying an additional 12,554 shares during the period. Dimensional Fund Advisors LP increased its stake in shares of Vitamin Shoppe by 22.4% in the second quarter. Dimensional Fund Advisors LP now owns 2,047,529 shares of the company’s stock worth $62,593,000 after buying an additional 374,360 shares during the period. Fuller & Thaler Asset Management Inc. increased its stake in shares of Vitamin Shoppe by 20.3% in the second quarter. Fuller & Thaler Asset Management Inc. now owns 1,695,043 shares of the company’s stock worth $51,817,000 after buying an additional 286,515 shares during the period. JPMorgan Chase & Co. increased its stake in shares of Vitamin Shoppe by 22.8% in the second quarter. JPMorgan Chase & Co. now owns 594,449 shares of the company’s stock worth $18,172,000 after buying an additional 110,395 shares during the period. Finally, Olstein Capital Management L.P. increased its stake in shares of Vitamin Shoppe by 13.2% in the second quarter. Olstein Capital Management L.P. now owns 534,945 shares of the company’s stock worth $16,353,000 after buying an additional 62,353 shares during the period.

This story is the sole property of American Banking News and it was originally published by American Banking News. If you are reading this story on another website, that means this article was illegally copied and re-published to this website in violation of U.S. and International copyright law. The original version of this article is available at http://www.americanbankingnews.com/2016/09/21/vitamin-shoppe-inc-nysevsi-receives-average-rating-of-hold-from-brokerages.html

Vitamin Shoppe (NYSE:VSI) traded up 1.25% during trading on Wednesday, reaching $26.70. The company’s stock had a trading volume of 92,086 shares. The company has a market cap of $629.69 million, a price-to-earnings ratio of 15.64 and a beta of 0.67. Vitamin Shoppe has a 12 month low of $26.02 and a 12 month high of $34.41. The stock’s 50 day moving average is $27.22 and its 200 day moving average is $29.36.

Vitamin Shoppe (NYSE:VSI) last released its earnings results on Wednesday, August 3rd. The company reported $0.55 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.59 by $0.04. The business earned $332.70 million during the quarter, compared to the consensus estimate of $331.58 million. Vitamin Shoppe had a net margin of 3.56% and a return on equity of 11.53%. The business’s revenue was up 3.2% on a year-over-year basis. During the same period in the prior year, the company earned $0.57 earnings per share. On average, equities analysts expect that Vitamin Shoppe will post $2.17 EPS for the current fiscal year.

About Vitamin Shoppe

Vitamin Shoppe, Inc (VSI) is a multi-channel specialty retailer and contract manufacturer of vitamins, minerals, herbs, specialty supplements, sports nutrition, and other health and wellness products. The Company operates through three segments: retail, which includes Vitamin Shoppe, Super Supplements and Vitapath retail store formats; direct, which sells its products directly to consumers through the Internet, primarily at www.vitaminshoppe.com, and manufacturing, which provides custom manufacturing and private labeling of vitamin, mineral and supplement (VMS) products.

5 Day Chart for NYSE:VSI

Receive News & Ratings for Vitamin Shoppe Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Vitamin Shoppe Inc. and related companies with MarketBeat.com's FREE daily email newsletter.